These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7855805)

  • 1. Rebuttal of the article of Bounameaux et al.
    Smith M; Kortmann C
    Thromb Haemost; 1994 Sep; 72(3):488-90. PubMed ID: 7855805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
    Barsotti A; Savarino A
    Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three D-dimer assays for the diagnosis of DVT:ELISA, latex and an immunofiltration assay (NycoCard D-Dimer).
    Dale S; Gogstad GO; Brosstad F; Godal HC; Holtlund J; Mørk E; Brandsnes O; Borch SM
    Thromb Haemost; 1994 Mar; 71(3):270-4. PubMed ID: 8029787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performances of the VIDAS D-dimer new assay for the exclusion of venous thromboembolism.
    de Moerloose P; Bounameaux H; Perrier A; Reber G
    Thromb Haemost; 2001 Jan; 85(1):185-6. PubMed ID: 11204577
    [No Abstract]   [Full Text] [Related]  

  • 5. SimpliRED D-dimer assay: comparability of capillary and citrated venous whole blood, between-assay variability, and performance of the test for exclusion of deep vein thrombosis in symptomatic outpatients.
    Mauron T; Baumgartner I; Z'Brun A; Demarmels Biasiutti F; Redondo M; Do DD; Lämmle B; Wuillemin WA
    Thromb Haemost; 1998 Jun; 79(6):1217-9. PubMed ID: 9657454
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview.
    Bounameaux H; de Moerloose P; Perrier A; Reber G
    Thromb Haemost; 1994 Jan; 71(1):1-6. PubMed ID: 8165626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of laboratory tests in the diagnosis of venous thromboembolism.
    Sié P
    Haematologica; 1995; 80(2 Suppl):57-60. PubMed ID: 7628772
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis.
    Janssen MC; Heebels AE; de Metz M; Verbruggen H; Wollersheim H; Janssen S; Schuurmans MM; Nováková IR
    Thromb Haemost; 1997 Feb; 77(2):262-6. PubMed ID: 9157578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exclusion of venous thromboembolism: evaluation of D-Dimer PLUS for the quantitative determination of D-dimer.
    Vermeer HJ; Ypma P; van Strijen MJ; Muradin AA; Hudig F; Jansen RW; Wijermans PW; Gerrits WB
    Thromb Res; 2005; 115(5):381-6. PubMed ID: 15733971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive evaluation of the instrumentation laboratory IL test D-Dimer immunoturbidimetric assay on the ACL 9000 determines the D-Dimer cutoff value for reliable exclusion of venous thromboembolism.
    Curtin N; Highe G; Harris M; Braunstein A; Demattia F; Coss L
    Lab Hematol; 2004; 10(2):88-94. PubMed ID: 15224764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolism and fibrinogen metabolism.
    Lancet; 1978 Jan; 1(8055):81-2. PubMed ID: 74576
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrin and fibrinogen degradation products in suspected deep venous thrombosis of the lower extremities].
    Sørensen MD; Ott P; Gad I; Gyhrs S; Iversen D; Treufeldt P
    Ugeskr Laeger; 1988 Jan; 150(1):20-2. PubMed ID: 3376204
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Proper observation of patient related factors is an important determinant in the utility of the D-dimer test for exclusion of venous thromboembolism in the ED.
    Ray P
    Am J Emerg Med; 2007 May; 25(4):485-6. PubMed ID: 17499677
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative evaluation of whole blood D-dimer test to plasma D-dimer test for diagnosis of disseminated intravascular coagulation.
    Gupta PK; Gupta M; Chatterjee T; Saxena R
    Indian J Exp Biol; 2005 Apr; 43(4):382-4. PubMed ID: 15875726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-dimer testing and acute venous thromboembolism. A shortcut to accurate diagnosis?
    Becker DM; Philbrick JT; Bachhuber TL; Humphries JE
    Arch Intern Med; 1996 May; 156(9):939-46. PubMed ID: 8624174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative analysis of crosslinked fibrin degradation products (XDP) in several diseases].
    Saito M; Asakura H; Ito K; Joukaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Ketsueki; 1988 Nov; 29(11):2042-7. PubMed ID: 3236412
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of D dimer assays for the diagnosis of deep vein thrombosis.
    Heaton DC; Billings JD; Hickton CM
    J Lab Clin Med; 1987 Nov; 110(5):588-91. PubMed ID: 3312443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrin-fibrinogen degradation products (F.D.P.) in thromboembolism and other diseases].
    Jones DR; Webber A; Prescott RJ; Allan NC; Ruckley CV
    Vasa; 1976; 5(4):332-7. PubMed ID: 1007541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.